{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "currency": "USD", "marketState": "PRE", "exchange": "NMS", "regularMarketChangePercent": -4.615386, "regularMarketPrice": 1.86, "firstTradeDateMilliseconds": 1555594200000, "priceHint": 4, "earningsTimestamp": 1683802860, "earningsTimestampStart": 1691584200, "earningsTimestampEnd": 1692016200, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -1.04, "epsForward": -1.01, "epsCurrentYear": -1.09, "priceEpsCurrentYear": -1.706422, "sharesOutstanding": 52322800, "bookValue": 1.874, "fiftyDayAverage": 0.97308, "fiftyDayAverageChange": 0.88692003, "fiftyDayAverageChangePercent": 0.91145647, "twoHundredDayAverage": 1.118315, "twoHundredDayAverageChange": 0.74168503, "twoHundredDayAverageChangePercent": 0.6632166, "marketCap": 97320408, "forwardPE": -1.8415842, "priceToBook": 0.9925294, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.1 - Buy", "tradeable": false, "cryptoTradeable": false, "shortName": "HOOKIPA Pharma Inc.", "longName": "HOOKIPA Pharma Inc.", "messageBoardId": "finmb_571641905", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "preMarketChange": -0.01999998, "preMarketChangePercent": -1.0752678, "preMarketTime": 1684226807, "preMarketPrice": 1.84, "regularMarketChange": -0.09000003, "regularMarketTime": 1684180805, "regularMarketDayHigh": 2.0, "regularMarketDayRange": "1.82 - 2.0", "regularMarketDayLow": 1.82, "regularMarketVolume": 1154357, "regularMarketPreviousClose": 1.95, "bid": 0.0, "ask": 0.0, "bidSize": 8, "askSize": 10, "fullExchangeName": "NasdaqGS", "financialCurrency": "USD", "regularMarketOpen": 1.94, "averageDailyVolume3Month": 700375, "averageDailyVolume10Day": 2392350, "fiftyTwoWeekLowChange": 1.1800001, "fiftyTwoWeekLowChangePercent": 1.7352942, "fiftyTwoWeekRange": "0.68 - 2.05", "fiftyTwoWeekHighChange": -0.18999994, "fiftyTwoWeekHighChangePercent": -0.0926829, "fiftyTwoWeekLow": 0.68, "fiftyTwoWeekHigh": 2.05, "displayName": "HOOKIPA Pharma", "symbol": "HOOK"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "350 Fifth Avenue", "address2": "72nd Floor Suite 7240", "city": "New York", "state": "NY", "zip": "10118", "country": "United States", "phone": "431 890 6360", "website": "https://www.hookipapharma.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transplantation from cytomegalovirus-positive donors. Its lead oncology product candidates are HB-201 and HB-202 that are in Phase I/II clinical trial for the treatment of human papillomavirus 16-positive cancers. The company's preclinical stage products include HB-300 program for prostate cancer; and HB-700 for targeting mutated KRAS in pancreatic, colorectal, and lung cancer. HOOKIPA Pharma Inc. has a collaboration with Gilead Sciences, Inc. to collaborate on preclinical research programs to evaluate potential vaccine products using or incorporating its replicating and non-replicating technology platforms for the treatment, cure, diagnosis, or prevention of Hepatitis B Virus. The company was incorporated in 2011 and is headquartered in New York, New York.", "fullTimeEmployees": 156, "companyOfficers": [{"maxAge": 1, "name": "Mr. Joern  Aldag", "age": 63, "title": "CEO & Director", "yearBorn": 1959, "fiscalYear": 2022, "totalPay": {"raw": 549338, "fmt": "549.34k", "longFmt": "549,338"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 281055, "fmt": "281.06k", "longFmt": "281,055"}}, {"maxAge": 1, "name": "Dr. Reinhard  Kandera Ph.D.", "age": 53, "title": "CFO & Director", "yearBorn": 1969, "fiscalYear": 2022, "totalPay": {"raw": 468305, "fmt": "468.31k", "longFmt": "468,305"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 77565, "fmt": "77.56k", "longFmt": "77,565"}}, {"maxAge": 1, "name": "Ms. Christine D. Baker M.B.A.", "age": 57, "title": "Chief Operating Officer", "yearBorn": 1965, "fiscalYear": 2022, "totalPay": {"raw": 610520, "fmt": "610.52k", "longFmt": "610,520"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Prof. Rolf M. Zinkernagel M.D., Ph.D.", "age": 78, "title": "Co-Founder", "yearBorn": 1944, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Andreas  Bergthaler", "title": "Co-Founder", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Lukas  Flatz", "title": "Co-Founder", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Klaus  Orlinger Ph.D.", "age": 44, "title": "Chief Scientific Officer", "yearBorn": 1978, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Matthew L. S. Beck", "title": "Exec. Director of Investor Relations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Michael  Szumera", "title": "Exec. Director of Communications", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Roman  Necina Ph.D.", "age": 54, "title": "Chief Devel. Officer", "yearBorn": 1968, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}